Table 1.
Demographic, psychiatric, medical, and HIV disease characteristics of the study groups.
| HIV− (n = 199) | HIV+ (n = 361) | p | |
|---|---|---|---|
| Age (years) | 42.8 (1.0) | 45.5 (0.6) | .058 |
| Education (years) | 14.3 (0.2) | 13.5 (0.1) | < .001 |
| Employment Status (% employed) | 77.9% | 77.9% | .187 |
| Gender (% men) | 65.3% | 85.9% | < .001 |
| Ethnicity | .743 | ||
| African American | 22.1% | 23.6% | -- |
| Asian | 2.0% | 1.4% | -- |
| Caucasian | 56.3% | 58.2% | -- |
| Hispanic | 18.1% | 16.3% | -- |
| Native American | 1.5% | 0.6% | -- |
| Verbal IQ (WTAR) | 103.8 (0.8) | 102.3 (0.6) | .170 |
| POMS Total Mood Disturbance | 42.8 (2.0) | 58.4 (2.0) | < .001 |
| Major Depression† | 33.3% | 57.7% | < .001 |
| Generalized Anxiety† | 4.6% | 14.0% | < .001 |
| Substance Dependence‡ | 38.7% | 54.6% | <.001 |
| Hepatitis C virus | 8.7% | 18.2% | 0.003 |
| HIV | |||
| Duration of Infection (months) | -- | 158.8 (5.2) | -- |
| AIDS | -- | 56.4% | -- |
| Current CD4 count | -- | 565.5 (15.3) | -- |
| Nadir CD4 count | -- | 211.9 (9.7) | -- |
| Prescribed ART | -- | 85.3% | -- |
| Plasma RNA detectable in those prescribed cART | -- | 25.9% | -- |
| -- | 15.9% | -- | |
Note. Data are presented as means (standard error) or percentages. POMS = Profile of Mood States; AIDS = Acquired Immune Deficiency Syndrome; CD4 = Cluster of Differentiation 4; ART = antiretroviral therapy.
†
Includes current and lifetime diagnoses.
‡
Any lifetime diagnosis of dependence on alcohol or illicit substance.